Evidence map›Paper›PMID 34198769›Full record

ReviewCancers2021

A Systematic Review of Biosynthesized Metallic Nanoparticles as a Promising Anti-Cancer-Strategy.

Anisa Andleeb, Aneeta Andleeb, Salman Asghar, Gouhar Zaman, Muhammad Tariq, Azra Mehmood, Muhammad Nadeem, Christophe Hano, Jose M Lorenzo, Bilal Haider Abbasi

Abstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Green-Synthesized Silver Nanoparticles fromAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Green Synthesis of Gold Nanoparticles UsingPharmaceuticals (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Zinc oxide fabricated by rutin as potent anti-leukemia nanostructure.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  15. Review
  16. Review
  17. Eco-friendly Synthesis ofPharmaceutical nanotechnology · 2025
    Review
  18. Article
  19. Article
  20. Green Synthesis and Characterization of Silver Nanoparticles UsingInternational journal of nanomedicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anisa AndleebPlant Cell and Tissue Culture Lab, Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan.
Aneeta AndleebProteomics Lab, School of Biochemistry & Biotechnology, University of the Punjab, Lahore 54590, Pakistan.
Salman AsgharMedia and Production Group, Centre for Media and Communication Studies, University of Gujrat, Gujrat 50700, Pakistan.
Gouhar ZamanPlant Cell and Tissue Culture Lab, Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan.
Muhammad TariqNanobiotechnology Group, Department of Biotechnology, Mirpur University of Science and Technology, Mirpur 10250, Pakistan.
Azra MehmoodStem Cell & Regenerative Medicine Lab, National Centre of Excellence in Molecular Biology, University of Punjab, 87-West Canal Bank Road, Lahore 53700, Pakistan.
Muhammad NadeemDepartment of Biotechnology, Institute of Integrative Biosciences, Peshawar 25100, Pakistan.
Christophe HanoLaboratoire de Biologie des Ligneux et des Grandes Cultures (LBLGC), INRA USC1328 Université ď Orléans, CEDEX 2, 45067 Orléans, France.ORCID 0000-0001-9938-0151
Jose M LorenzoCentro Tecnológico de la Carne de Galicia, Avd. Galicia no 4, Parque Tecnológico de Galicia, San Cibrao das Viñas, 32900 Ourense, Spain.ORCID 0000-0002-7725-9294
Bilal Haider AbbasiPlant Cell and Tissue Culture Lab, Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan.ORCID 0000-0002-6529-2134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is one of the foremost causes of death worldwide. Cancer develops because of mutation in genes that regulate normal cell cycle and cell division, thereby resulting in uncontrolled division and proliferation of cells. Various drugs have been used to treat cancer thus far; however, conventional chemotherapeutic drugs have lower bioavailability, rapid renal clearance, unequal delivery, and severe side effects. In the recent years, nanotechnology has flourished rapidly and has a multitude of applications in the biomedical field. Bio-mediated nanoparticles (NPs) are cost effective, safe, and biocompatible and have got substantial attention from researchers around the globe. Due to their safe profile and fewer side effects, these nanoscale materials offer a promising cure for cancer. Currently, various metallic NPs have been designed to cure or diagnose cancer; among these, silver (Ag), gold (Au), zinc (Zn) and copper (Cu) are the leading anti-cancer NPs. The anticancer potential of these NPs is attributed to the production of reactive oxygen species (ROS) in cellular compartments that eventually leads to activation of autophagic, apoptotic and necrotic death pathways. In this review, we summarized the recent advancements in the biosynthesis of Ag, Au, Zn and Cu NPs with emphasis on their mechanism of action. Moreover, nanotoxicity, as well as the future prospects and opportunities of nano-therapeutics, are also highlighted.

Indexed as

anti-cancer effectcancercancer developmentgreen synthesismetallic NPs

Identifiers

PMID34198769
PMCPMC8201057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.